EPP (Edinburgh Pharmaceutical Processes Ltd) is a GLP Contract Research Organisation offering specialized analytical and development services for research and development in the biotechnology and pharmaceutical industries. With over 30 years of experience, EPP assists companies in achieving product registration worldwide and provides support for REACH testing, including 5-BATCH and physico-chemical testing.
EPP operates within the agrochemical, human and animal pharmaceutical, and industrial chemical sectors. The company prides itself on being the GLP contract research organisation of choice, emphasizing the combination of value for money with superior service quality delivered by experienced and technically expert scientists.
The company's approach is centered around providing integrated and specialist analytical and development services of consistently superior quality, underpinned by expert competencies in screening, synthesis, and analytical services. Its innovative approach and unmatched performance position EPP as a trusted and reliable partner, establishing the company as the preferred CRO.
Cost and time-conscious, EPP uses a practical tailored approach to ensure competitive pricing. By focusing on delivering outcomes and fostering long-term partnerships with customers, the company consistently brings cost-effectiveness to the table.
There is no investment information
No recent news or press coverage available for EPP (Edinburgh Pharmaceutical Processes Ltd).